Ask AI
ProCE Banner Activity

Innovations in Pancreatic Cancer: KRAS and Beyond

Slideset

Download this slideset featuring the latest data and expert insights on the current treatment landscape in locally advanced and metastatic pancreatic cancer. Topics covered include current standards of care in the frontline setting, biomarker-driven treatment with a focus on emerging RAS-targeted agents, and supportive care strategies.

Released: May 29, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the Pancreatic Cancer Action Network (PanCAN).

ProCE Banner

Supporters

Supported by educational grants from Novocure and Revolution Medicines, Inc.

Novocure

Revolution Medicines, Inc.

Partners

Pancreatic Cancer Action Network (PanCAN)

ProCE Banner

Target Audience

This activity is designed for community oncologists, advanced practice providers, oncology nurses, pharmacists, and other healthcare professionals involved in the multidisciplinary care of patients with pancreatic cancer across all disease stages, aiming to improve frontline and later-line treatment outcomes.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess emerging biomarker and molecular profiling data to guide personalized treatment decisions that incorporate novel therapeutic modalities

  • Select frontline and subsequent therapies for pancreatic cancer using current clinical evidence and guideline-based criteria, tailored to disease stage, patient performance status, and molecular biomarker profiles

  • Implement practical dose modification, toxicity monitoring, and supportive care strategies to manage gastrointestinal, hematologic, and neuropathic adverse events associated with pancreatic cancer therapies